Clinical and Radiographic Outcomes of PRF, Chitosan, and Blood Clot in Regenerative Endodontics of Molars

Inonu University

Status: Completed

Conditions: Regenerative Endodontics

Treatments: Procedure: Regenerative Endodontic Treatment Using a Platelet Rich Fibrin as a Scaffold; Procedure: Regenerative Endodontic Treatment Using a Chitosan as a Scaffold; Procedure: Regenerative Endodontic Treatment Using a Blood Clot as a Scaffold

Study type: Interventional

Funder types: Other

Identifiers

NCT07119619

TDH-2023-3161 (Other Grant/Funding Number)

2022/64

Details and patient eligibility

About

This clinical trial aimed to evaluate the long-term effects of using chitosan, blood clots, and platelet-rich fibrin as scaffolds in regenerative endodontics on tooth development. The trial aimed to answer the following questions:

Does chitosan shorten the duration of treatment for participants? Does chitosan promote root development? Which scaffold is most effective for root development? Which scaffold is more practical and effective to use in pediatric patients? Participants underwent regenerative endodontic treatment and were called to the clinic every six months for symptom assessment. Clinical and radiographic records were kept.

Full description

Regenerative endodontic treatments are biologically based procedures designed to physiologically replace damaged tooth structures, including the cells of the pulp-dentin complex. The aim of this treatment is to promote normal root development in immature permanent teeth with necrotic pulp.The primary goal of regenerative endodontics is to stimulate stem cells and encourage their division and proliferation to regenerate damaged tissue. However, a scaffold is essential for the survival of stem cells throughout the regeneration process. A key component of this process is the presence of a scaffold that allows stem cells from the apical papilla to adhere, proliferate, and differentiate. Blood clots and platelet-rich fibrin are frequently used as scaffolds in regenerative endodontics. However, research is ongoing to determine the appropriate scaffold for cases where these are not applicable.Researchers investigated an alternative scaffold for children who could not achieve apical bleeding or allow blood collection from the arm for PRF. Due to its biocompatibility, low cost, and broad-spectrum antibacterial activity, chitosan was included as the third group in this study. The immature necrotic molars to be treated were randomly divided into three groups. Regenerative endodontic treatment was performed using three different scaffolds: blood clot, PRF, and chitosan. The results were evaluated radiographically and clinically.

Enrollment: 28 patients

Sex: All

Ages: 6 to 14 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Patient Selection Criteria

• Being between the ages of 6-14
• Not having any systemic disease
• Not using any regular medication
• Not having any detected allergies
• The patient must be able to cooperate to the extent that the treatment can be applied healthily
• The patient's guardian must agree to participate in the study

Selection Criteria of Teeth • Restorable necrotic immature first and second permanent mandibular molars with two roots and a root development stage of 3 or 4 according to Cvek's classification

Exclusion criteria

• Failure to meet the patient and tooth selection criteria mentioned above

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

28 participants in 3 patient groups

Chitosan

Other group

Treatment:

Procedure: Regenerative Endodontic Treatment Using a Chitosan as a Scaffold

Platelet-rich fibrin

Other group

Treatment:

Procedure: Regenerative Endodontic Treatment Using a Platelet Rich Fibrin as a Scaffold

Blood clot

Other group

Treatment:

Procedure: Regenerative Endodontic Treatment Using a Blood Clot as a Scaffold